Expert in MASH

Explore our industry-leading
translational models of MASH & MASH-HCC

Gubra’s flagship model GAN DIO-MASH is top-ranked by LITMUS consortium for its human proximity score and clinical translatability. Explore our model portfolio and latest findings to ensure a successful preclinical study.

Explore our data

Download Gubra’s EASL Posters

Check out our posters at EASL and discover the clinical translatability of our flagship GAN DIO-MASH model, as well as other biopsy-confirmed preclinical models.

Clinical translatability of the GAN diet-induced obese and biopsy-confirmed mouse model of MASH

Poster number: THU-208
6 June (Thu) 12:30 – 14:00

Download

Additive hepatoprotective effects of semaglutide and resmetirom in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH

Poster number: THU-244
6 June (Thu) 12:30 – 14:00

Download

Additive hepatoprotective effects of DA-1241, a novel GPR119 agonist, in combination with semaglutide in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH

Poster number : THU-232
6 June (Thu) 12:30 – 14:00

Download

Histological and molecular characterization of the GAN diet-induced obese mouse model of advanced MASH with progression to advanced fibrosis and HCC

Poster number : FRI-478
7 June (Fri) 12:30 – 14:00

Download

Prophylactic and therapeutic effects of the dual FXR/TGR5 agonist INT-767 in the GAN diet-induced ob/ob mouse model of advanced MASH with progressive fibrosis

Poster number: THU-202
6 June (Thu) 12:30 – 14:00

Download

Hepatoprotective effects of a HSD17b13 inhibitor in the CDAA-HFD mouse model of advanced MASH with progressive fibrosis

Poster number: THU-211
6 June (Thu) 12:30 – 14:00

Download

Hepatic immune cell profiling of the GAN diet-induced obese and biopsy-confirmed mouse model of MASH with advanced fibrosis and HCC

Download